AustralieFrV1, PubMed, Curation, bibRecord, 001E37

Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations.

Identifieur interne : 001E37 ( PubMed/Curation ); précédent : 001E36; suivant : 001E38

Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations.

Auteurs : Hema Sundaram ; Steven Liew ; Massimo Signorini ; André Vieira Braz ; Steven Fagien ; Arthur Swift ; Koenraad L. De Boulle ; Hervé Raspaldo ; Ada R. Trindade De Almeida ; Gary Monheit

Source :

Plastic and reconstructive surgery [ 1529-4242 ] ; 2016.

RBID : pubmed:27119917

Descripteurs français

KwdFr :
- Acide hyaluronique (administration et posologie), Adulte, Adulte d'âge moyen, Association thérapeutique, Enfant, Face, Groupes ethniques, Humains, Nourrisson, Produits de comblement dermique (administration et posologie), Rajeunissement, Techniques cosmétiques, Toxines botuliniques de type A (administration et posologie), Vieillissement de la peau, Élasticité.
MESH :
- administration et posologie : Acide hyaluronique, Produits de comblement dermique, Toxines botuliniques de type A.
- Adulte, Adulte d'âge moyen, Association thérapeutique, Enfant, Face, Groupes ethniques, Humains, Nourrisson, Rajeunissement, Techniques cosmétiques, Vieillissement de la peau, Élasticité.

English descriptors

KwdEn :
- Adult, Botulinum Toxins, Type A (administration & dosage), Child, Combined Modality Therapy, Cosmetic Techniques, Dermal Fillers (administration & dosage), Elasticity, Ethnic Groups, Face, Humans, Hyaluronic Acid (administration & dosage), Infant, Middle Aged, Rejuvenation, Skin Aging.
MESH :
- chemical , administration & dosage : Botulinum Toxins, Type A, Dermal Fillers, Hyaluronic Acid.
- Adult, Child, Combined Modality Therapy, Cosmetic Techniques, Elasticity, Ethnic Groups, Face, Humans, Infant, Middle Aged, Rejuvenation, Skin Aging.

Abstract

Combination of fillers and botulinum toxin for aesthetic applications is increasingly popular. Patient demographics continue to diversify, and include an expanding population receiving maintenance treatments over decades.

DOI: 10.1097/PRS.0000000000002119
PubMed: 27119917

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001E61

Links to Exploration step

pubmed:27119917

Curation

No country items

Hema Sundaram

<affiliation><nlm:affiliation>Rockville, Md.; Sydney, New South Wales, Australia; Milan, Italy; Rio de Janeiro and Sao Paulo, Brazil; Boca Raton, Fla.; Montreal, Quebec, Canada; Aalst, Belgium; Cannes, France; and Birmingham, Ala.</nlm:affiliation>
<wicri:noCountry code="subField">Ala</wicri:noCountry>
</affiliation>

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations.</title>
<author><name sortKey="Sundaram, Hema" sort="Sundaram, Hema" uniqKey="Sundaram H" first="Hema" last="Sundaram">Hema Sundaram</name>
<affiliation><nlm:affiliation>Rockville, Md.; Sydney, New South Wales, Australia; Milan, Italy; Rio de Janeiro and Sao Paulo, Brazil; Boca Raton, Fla.; Montreal, Quebec, Canada; Aalst, Belgium; Cannes, France; and Birmingham, Ala.</nlm:affiliation>
<wicri:noCountry code="subField">Ala</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Liew, Steven" sort="Liew, Steven" uniqKey="Liew S" first="Steven" last="Liew">Steven Liew</name>
</author>
<author><name sortKey="Signorini, Massimo" sort="Signorini, Massimo" uniqKey="Signorini M" first="Massimo" last="Signorini">Massimo Signorini</name>
</author>
<author><name sortKey="Vieira Braz, Andre" sort="Vieira Braz, Andre" uniqKey="Vieira Braz A" first="André" last="Vieira Braz">André Vieira Braz</name>
</author>
<author><name sortKey="Fagien, Steven" sort="Fagien, Steven" uniqKey="Fagien S" first="Steven" last="Fagien">Steven Fagien</name>
</author>
<author><name sortKey="Swift, Arthur" sort="Swift, Arthur" uniqKey="Swift A" first="Arthur" last="Swift">Arthur Swift</name>
</author>
<author><name sortKey="De Boulle, Koenraad L" sort="De Boulle, Koenraad L" uniqKey="De Boulle K" first="Koenraad L" last="De Boulle">Koenraad L. De Boulle</name>
</author>
<author><name sortKey="Raspaldo, Herve" sort="Raspaldo, Herve" uniqKey="Raspaldo H" first="Hervé" last="Raspaldo">Hervé Raspaldo</name>
</author>
<author><name sortKey="Trindade De Almeida, Ada R" sort="Trindade De Almeida, Ada R" uniqKey="Trindade De Almeida A" first="Ada R" last="Trindade De Almeida">Ada R. Trindade De Almeida</name>
</author>
<author><name sortKey="Monheit, Gary" sort="Monheit, Gary" uniqKey="Monheit G" first="Gary" last="Monheit">Gary Monheit</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27119917</idno>
<idno type="pmid">27119917</idno>
<idno type="doi">10.1097/PRS.0000000000002119</idno>
<idno type="wicri:Area/PubMed/Corpus">001E61</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E61</idno>
<idno type="wicri:Area/PubMed/Curation">001E37</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001E37</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations.</title>
<author><name sortKey="Sundaram, Hema" sort="Sundaram, Hema" uniqKey="Sundaram H" first="Hema" last="Sundaram">Hema Sundaram</name>
<affiliation><nlm:affiliation>Rockville, Md.; Sydney, New South Wales, Australia; Milan, Italy; Rio de Janeiro and Sao Paulo, Brazil; Boca Raton, Fla.; Montreal, Quebec, Canada; Aalst, Belgium; Cannes, France; and Birmingham, Ala.</nlm:affiliation>
<wicri:noCountry code="subField">Ala</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Liew, Steven" sort="Liew, Steven" uniqKey="Liew S" first="Steven" last="Liew">Steven Liew</name>
</author>
<author><name sortKey="Signorini, Massimo" sort="Signorini, Massimo" uniqKey="Signorini M" first="Massimo" last="Signorini">Massimo Signorini</name>
</author>
<author><name sortKey="Vieira Braz, Andre" sort="Vieira Braz, Andre" uniqKey="Vieira Braz A" first="André" last="Vieira Braz">André Vieira Braz</name>
</author>
<author><name sortKey="Fagien, Steven" sort="Fagien, Steven" uniqKey="Fagien S" first="Steven" last="Fagien">Steven Fagien</name>
</author>
<author><name sortKey="Swift, Arthur" sort="Swift, Arthur" uniqKey="Swift A" first="Arthur" last="Swift">Arthur Swift</name>
</author>
<author><name sortKey="De Boulle, Koenraad L" sort="De Boulle, Koenraad L" uniqKey="De Boulle K" first="Koenraad L" last="De Boulle">Koenraad L. De Boulle</name>
</author>
<author><name sortKey="Raspaldo, Herve" sort="Raspaldo, Herve" uniqKey="Raspaldo H" first="Hervé" last="Raspaldo">Hervé Raspaldo</name>
</author>
<author><name sortKey="Trindade De Almeida, Ada R" sort="Trindade De Almeida, Ada R" uniqKey="Trindade De Almeida A" first="Ada R" last="Trindade De Almeida">Ada R. Trindade De Almeida</name>
</author>
<author><name sortKey="Monheit, Gary" sort="Monheit, Gary" uniqKey="Monheit G" first="Gary" last="Monheit">Gary Monheit</name>
</author>
</analytic>
<series><title level="j">Plastic and reconstructive surgery</title>
<idno type="eISSN">1529-4242</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Botulinum Toxins, Type A (administration & dosage)</term>
<term>Child</term>
<term>Combined Modality Therapy</term>
<term>Cosmetic Techniques</term>
<term>Dermal Fillers (administration & dosage)</term>
<term>Elasticity</term>
<term>Ethnic Groups</term>
<term>Face</term>
<term>Humans</term>
<term>Hyaluronic Acid (administration & dosage)</term>
<term>Infant</term>
<term>Middle Aged</term>
<term>Rejuvenation</term>
<term>Skin Aging</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Acide hyaluronique (administration et posologie)</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Association thérapeutique</term>
<term>Enfant</term>
<term>Face</term>
<term>Groupes ethniques</term>
<term>Humains</term>
<term>Nourrisson</term>
<term>Produits de comblement dermique (administration et posologie)</term>
<term>Rajeunissement</term>
<term>Techniques cosmétiques</term>
<term>Toxines botuliniques de type A (administration et posologie)</term>
<term>Vieillissement de la peau</term>
<term>Élasticité</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Botulinum Toxins, Type A</term>
<term>Dermal Fillers</term>
<term>Hyaluronic Acid</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Acide hyaluronique</term>
<term>Produits de comblement dermique</term>
<term>Toxines botuliniques de type A</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Child</term>
<term>Combined Modality Therapy</term>
<term>Cosmetic Techniques</term>
<term>Elasticity</term>
<term>Ethnic Groups</term>
<term>Face</term>
<term>Humans</term>
<term>Infant</term>
<term>Middle Aged</term>
<term>Rejuvenation</term>
<term>Skin Aging</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Association thérapeutique</term>
<term>Enfant</term>
<term>Face</term>
<term>Groupes ethniques</term>
<term>Humains</term>
<term>Nourrisson</term>
<term>Rajeunissement</term>
<term>Techniques cosmétiques</term>
<term>Vieillissement de la peau</term>
<term>Élasticité</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Combination of fillers and botulinum toxin for aesthetic applications is increasingly popular. Patient demographics continue to diversify, and include an expanding population receiving maintenance treatments over decades.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27119917</PMID>
<DateCreated><Year>2016</Year>
<Month>04</Month>
<Day>28</Day>
</DateCreated>
<DateCompleted><Year>2016</Year>
<Month>12</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-4242</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>137</Volume>
<Issue>5</Issue>
<PubDate><Year>2016</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Plastic and reconstructive surgery</Title>
<ISOAbbreviation>Plast. Reconstr. Surg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations.</ArticleTitle>
<Pagination><MedlinePgn>1410-23</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/PRS.0000000000002119</ELocationID>
<Abstract><AbstractText Label="BACKGROUND">Combination of fillers and botulinum toxin for aesthetic applications is increasingly popular. Patient demographics continue to diversify, and include an expanding population receiving maintenance treatments over decades.</AbstractText>
<AbstractText Label="METHODS">A multinational panel of plastic surgeons and dermatologists convened the Global Aesthetics Consensus Group to develop updated guidelines with a worldwide perspective for hyaluronic acid fillers and botulinum toxin. This publication considers strategies for combined treatments, and how patient diversity influences treatment planning and outcomes.</AbstractText>
<AbstractText Label="RESULTS">Global Aesthetics Consensus Group recommendations reflect increased use of combined treatments in the lower and upper face, and some midface regions. A fully patient-tailored approach considers physiologic and chronologic age, ethnically associated facial morphotypes, and aesthetic ideals based on sex and culture. Lower toxin dosing, to modulate rather than paralyze muscles, is indicated where volume deficits influence muscular activity. Combination of toxin with fillers is appropriate for several indications addressed previously with toxin alone. New scientific data regarding hyaluronic acid fillers foster an evidence-based approach to selection of products and injection techniques. Focus on aesthetic units, rather than isolated rhytides, optimizes results from toxin and fillers. It also informs longitudinal treatment planning, and analysis of toxin nonresponders.</AbstractText>
<AbstractText Label="CONCLUSIONS">The emerging objective of injectable treatment is facial harmonization rather than rejuvenation. Combined treatment is now a standard of care. Its use will increase further as we refine the concept that aspects of aging are intimately related, and that successful treatment entails identifying and addressing the primary causes of each.</AbstractText>
<AbstractText Label="CLINICAL QUESTION/LEVEL OF EVIDENCE">Therapeutic, V.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sundaram</LastName>
<ForeName>Hema</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Rockville, Md.; Sydney, New South Wales, Australia; Milan, Italy; Rio de Janeiro and Sao Paulo, Brazil; Boca Raton, Fla.; Montreal, Quebec, Canada; Aalst, Belgium; Cannes, France; and Birmingham, Ala.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Liew</LastName>
<ForeName>Steven</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Signorini</LastName>
<ForeName>Massimo</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Vieira Braz</LastName>
<ForeName>André</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Fagien</LastName>
<ForeName>Steven</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Swift</LastName>
<ForeName>Arthur</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>De Boulle</LastName>
<ForeName>Koenraad L</ForeName>
<Initials>KL</Initials>
</Author>
<Author ValidYN="Y"><LastName>Raspaldo</LastName>
<ForeName>Hervé</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y"><LastName>Trindade de Almeida</LastName>
<ForeName>Ada R</ForeName>
<Initials>AR</Initials>
</Author>
<Author ValidYN="Y"><LastName>Monheit</LastName>
<ForeName>Gary</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><CollectiveName>Global Aesthetics Consensus Group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016446">Consensus Development Conference</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017065">Practice Guideline</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Plast Reconstr Surg</MedlineTA>
<NlmUniqueID>1306050</NlmUniqueID>
<ISSNLinking>0032-1052</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000067548">Dermal Fillers</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>9004-61-9</RegistryNumber>
<NameOfSubstance UI="D006820">Hyaluronic Acid</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.24.69</RegistryNumber>
<NameOfSubstance UI="D019274">Botulinum Toxins, Type A</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Exp Dermatol. 2004;13 Suppl 4:27-30</RefSource>
<PMID Version="1">15507109</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Plast Surg. 2008 Jul;35(3):319-27; discussion 317</RefSource>
<PMID Version="1">18558224</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Aesthetic Plast Surg. 2002 Jan-Feb;26(1):64-9</RefSource>
<PMID Version="1">11891603</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 2012 Jul;130(1):208-17</RefSource>
<PMID Version="1">22743885</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cosmet Dermatol. 2011 Mar;10(1):36-50</RefSource>
<PMID Version="1">21332914</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 2007 Jun;119(7):2219-27; discussion 2228-31</RefSource>
<PMID Version="1">17519724</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2010 Nov;36 Suppl 3:1833-41</RefSource>
<PMID Version="1">20969660</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 2010 Jan;125(1):332-42</RefSource>
<PMID Version="1">20048624</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Drugs Dermatol. 2008 Sep;7(9):847-50</RefSource>
<PMID Version="1">19112798</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2012 Sep;38(9):1506-15</RefSource>
<PMID Version="1">22804914</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Otolaryngol Head Neck Surg. 1996 Oct;122(10):1079-86</RefSource>
<PMID Version="1">8859120</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2009 Mar;35(3):429-35; discussion 435-6</RefSource>
<PMID Version="1">19250310</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cosmet Dermatol. 2011 Jun;10(2):131-49</RefSource>
<PMID Version="1">21649819</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 2008 Jun;121(6):2107-12</RefSource>
<PMID Version="1">18520902</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Cosmet Sci. 2006 Apr;28(2):79-93</RefSource>
<PMID Version="1">18492142</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2005 Mar;31(3):271-5</RefSource>
<PMID Version="1">15841625</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2015 Apr;41 Suppl 1:S120-6</RefSource>
<PMID Version="1">25828036</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 2016 Mar;137(3):518e-529e</RefSource>
<PMID Version="1">26910696</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BioDrugs. 2012 Apr 1;26(2):e1-9</RefSource>
<PMID Version="1">22385408</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 2013 Oct;132(4 Suppl 2):5S-21S</RefSource>
<PMID Version="1">24077013</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Facial Plast Surg Clin North Am. 2002 Nov;10(4):343-9</RefSource>
<PMID Version="1">15062295</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 2009 Jul;124(1):266-71</RefSource>
<PMID Version="1">19568090</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 2011 Jan;127(1):384-5</RefSource>
<PMID Version="1">21200233</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Facial Plast Surg. 2000 Apr-Jun;2(2):113-20</RefSource>
<PMID Version="1">10925436</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Aesthetic Plast Surg. 2000 May-Jun;24(3):179-84</RefSource>
<PMID Version="1">10890944</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Dermatol Sci. 2009 Sep;55(3):144-9</RefSource>
<PMID Version="1">19574028</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Cosmet Investig Dermatol. 2012;5:93-9</RefSource>
<PMID Version="1">22956881</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 2008 May;121(5 Suppl):5S-30S; quiz 31S-36S</RefSource>
<PMID Version="1">18449026</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Plast Surg. 2013 Jan;40(1):55-76</RefSource>
<PMID Version="1">23186756</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 2009 Sep;124(3):946-51</RefSource>
<PMID Version="1">19730316</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Otolaryngol Head Neck Surg. 2014 Jun;150(6):949-55</RefSource>
<PMID Version="1">24664544</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2013 Mar;39(3 Pt 2):510-25</RefSource>
<PMID Version="1">23458295</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cosmet Laser Ther. 2011 Feb;13(1):21-7</RefSource>
<PMID Version="1">21254807</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2007 Dec;33 Suppl 2:S128-35</RefSource>
<PMID Version="1">18086050</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2008 May 07;3(5):e2106</RefSource>
<PMID Version="1">18461131</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Drugs Dermatol. 2009 May;8(5 Suppl Skin Rejuenation):4-13</RefSource>
<PMID Version="1">19562882</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Cosmet Dermatol. 2009 Sep;8(3):162-8</RefSource>
<PMID Version="1">19735512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2012 Jul;38(7 Pt 2):1162-9</RefSource>
<PMID Version="1">22759253</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2013 Oct;39(10):1434-43</RefSource>
<PMID Version="1">24090254</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2007 Dec;33 Suppl 2:S144-51</RefSource>
<PMID Version="1">18086052</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2011 May;37(5):637-43</RefSource>
<PMID Version="1">21272119</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Forensic Sci Int. 2007 Oct 2;172(1):1-9</RefSource>
<PMID Version="1">17434276</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2015 Jan;41 Suppl 1:S19-28</RefSource>
<PMID Version="1">25548841</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 2015 Oct;136(4):678-86</RefSource>
<PMID Version="1">26397245</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Aesthet Surg J. 2006 Jan-Feb;26(1S):S4-9</RefSource>
<PMID Version="1">19338976</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Photochem Photobiol. 1993 Dec;58(6):841-4</RefSource>
<PMID Version="1">8310007</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 2007 Oct;120(5):1367-76; discussion 1377</RefSource>
<PMID Version="1">17898614</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2010 Oct 15;25(13):2211-8</RefSource>
<PMID Version="1">20737546</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 1999 Feb;103(2):635-44</RefSource>
<PMID Version="1">9950555</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neurology. 2003 Apr 8;60(7):1186-8</RefSource>
<PMID Version="1">12682332</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Am Acad Dermatol. 2002 Feb;46(2 Suppl Understanding):S41-62</RefSource>
<PMID Version="1">11807469</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Drugs Dermatol. 2014 Apr;13(4):386-8</RefSource>
<PMID Version="1">24719056</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2010 Dec;36 Suppl 4:2121-34</RefSource>
<PMID Version="1">21134044</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Plast Reconstr Surg. 2013 Oct;132(4 Suppl 2):41S-47S</RefSource>
<PMID Version="1">24077010</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2013 Mar;39(3 Pt 1):443-8</RefSource>
<PMID Version="1">23293895</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2010 Nov;36 Suppl 3:1859-65</RefSource>
<PMID Version="1">20969663</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2005 Mar;31(3):257-62</RefSource>
<PMID Version="1">15841623</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2009 Feb;35 Suppl 1:302-12</RefSource>
<PMID Version="1">19207319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2014 Aug;40(8):832-41</RefSource>
<PMID Version="1">25022707</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Gend Med. 2007 Dec;4(4):308-28</RefSource>
<PMID Version="1">18215723</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Plast Reconstr Aesthet Surg. 2010 Nov;63(11):1825-31</RefSource>
<PMID Version="1">19962360</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Dermatol Surg. 2010 Nov;36 Suppl 3:1852-8</RefSource>
<PMID Version="1">20969662</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Dermatol. 2008 Dec;47(12):1287-94</RefSource>
<PMID Version="1">19126019</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Ther. 2007 Apr;29(4):683-90</RefSource>
<PMID Version="1">17617291</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Cosmet Investig Dermatol. 2013 Dec 18;7:11-7</RefSource>
<PMID Version="1">24379687</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Aesthetic Plast Surg. 2012 Aug;36(4):753-60</RefSource>
<PMID Version="1">22580543</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019274" MajorTopicYN="N">Botulinum Toxins, Type A</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003357" MajorTopicYN="Y">Cosmetic Techniques</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000067548" MajorTopicYN="N">Dermal Fillers</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004548" MajorTopicYN="N">Elasticity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005006" MajorTopicYN="N">Ethnic Groups</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005145" MajorTopicYN="N">Face</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006820" MajorTopicYN="N">Hyaluronic Acid</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012060" MajorTopicYN="N">Rejuvenation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015595" MajorTopicYN="N">Skin Aging</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<InvestigatorList><Investigator ValidYN="Y"><LastName>Braz</LastName>
<ForeName>André Vieira</ForeName>
<Initials>AV</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Carruthers</LastName>
<ForeName>JeanD A</ForeName>
<Initials>JA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>De Boulle</LastName>
<ForeName>KoenraadL</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Fagien</LastName>
<ForeName>Steven</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Goodman</LastName>
<ForeName>GregJ</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lee</LastName>
<ForeName>Soo-Keun</ForeName>
<Initials>SK</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Liew</LastName>
<ForeName>Steven</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Monheit</LastName>
<ForeName>Gary</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Raspaldo</LastName>
<ForeName>Hervé</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rohrich</LastName>
<ForeName>RodJ</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sattler</LastName>
<ForeName>Gerhard</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Signorini</LastName>
<ForeName>Massimo</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sundaram</LastName>
<ForeName>Hema</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Swift</LastName>
<ForeName>Arthur</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Trindade de Almeida</LastName>
<ForeName>AdaR</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wu</LastName>
<ForeName>Yan</ForeName>
<Initials>Y</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>4</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>4</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>12</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27119917</ArticleId>
<ArticleId IdType="doi">10.1097/PRS.0000000000002119</ArticleId>
<ArticleId IdType="pii">00006534-201605000-00011</ArticleId>
<ArticleId IdType="pmc">PMC5242215</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E37 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001E37 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:27119917
   |texte=   Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:27119917" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations.

Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Curation

No country items

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki